STATISTICAL QUESTION Clinical trials: outcome measures

被引：4
|
作者：
Sedgwick, Philip [1 ]
机构：
[1] Univ London, Inst Med & Biomed Educ, London, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 350卷
关键词：
D O I：
10.1136/bmj.h121
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] STATISTICAL QUESTION Confounding in clinical trials
    Sedgwick, Philip
    BRITISH MEDICAL JOURNAL, 2012, 345
  • [2] Statistical Question Phases of clinical trials
    Sedgwick, Philip
    BRITISH MEDICAL JOURNAL, 2011, 343
  • [3] Outcome measures in clinical trials
    Heyse, JF
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (02) : 87 - 87
  • [4] Measures of alcohol treatment outcome in randomized clinical trials: Prevalence and rates of statistical significance
    Wibourne, PL
    Miller, WR
    Finney, JW
    Tonigan, JS
    Bogenshutz, M
    Johnson, W
    Daugherty, M
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 112A - 112A
  • [5] STATISTICAL QUESTION External and internal validity in clinical trials
    Sedgwick, Philip
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [6] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [7] Outcome Measures for Clinical Trials in Down Syndrome
    Esbensen, Anna J.
    Hooper, Stephen R.
    Fidler, Deborah
    Hartley, Sigan L.
    Edgin, Jamie
    d'Ardhuy, Xavier Liogier
    Capone, George
    Conners, Frances A.
    Mervis, Carolyn B.
    Abbeduto, Leonard
    Rafii, Michael
    Krinsky-McHale, Sharon J.
    Urv, Tiina
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2017, 122 (03): : 247 - 281
  • [8] OUTCOME MEASURES FOR CLINICAL-TRIALS IN RHEUMATOLOGY
    TUGWELL, P
    BUCHANAN, W
    BOMBARDIER, C
    EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION, 1983, 6 (02) : 140 - 141
  • [9] Outcome measures for clinical drug trials in autism
    Aman, MG
    Novotny, S
    Samango-Sprouse, C
    Lecavalier, L
    Leonard, E
    Gadow, KD
    King, BH
    Pearson, DA
    Gernsbacher, MA
    Chez, M
    CNS SPECTRUMS, 2004, 9 (01) : 36 - 47
  • [10] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
12345